Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novotech
Research
Holoclara wriggles into ph. 1, sets sights on immune disease
The drug candidate being tested, HC002, is an oral small molecule that was originally sourced from roundworms that live in our guts.
Darren Incorvaia
Dec 18, 2024 9:05am
Number of esophageal cancer trials rise with incidence rate
Jul 31, 2024 3:20pm
Europe leads in cystic fibrosis trials, North America for AML
Apr 16, 2024 5:00pm
Asia-Pacific CRO Novotech makes US play with NCGS acquisition
May 4, 2022 1:39pm
ObvioHealth picks up $31M amid booming virtual clinical trials
Jul 1, 2021 9:00am
Novotech, PPC turn partnership into merger
Oct 15, 2020 3:00am
